Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12–49. https://doi.org/10.3322/caac.21820.

Article  PubMed  Google Scholar 

Tan K, Naylor M. The influence of modifiable factors on breast and prostate cancer risk and disease progression. Front Physiol. 2022. https://doi.org/10.3389/fphys.2022.840826.

Article  PubMed  PubMed Central  Google Scholar 

Quinn TJ, Chapman D, Parzen J, Wahl DR, McNamara A, Dess R, Chan J, Feng F, Jackson WC, Hamstra D. Validation of the combination gleason score as an independent favorable prognostic factor in prostate cancer treated with dose-escalated radiation therapy. Pract Radiat Oncol. 2023;13(2):e166–75. https://doi.org/10.1016/j.prro.2022.08.013.

Article  PubMed  Google Scholar 

Hamdy F, Donovan J, Lane J, Mason M, Metcalfe C, Holding P, Davis M, Peters T, Turner E, Martin R, Oxley J, Robinson M, Staffurth J, Walsh E, Bollina P, Catto J, Doble A, Doherty A, Gillatt D, Kockelbergh R, Kynaston H, Paul A, Powell P, Prescott S, Rosario D, Rowe E, Neal D, Neal D. 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 2017;375(15):1415–24. https://doi.org/10.1056/NEJMoa1606220.

Article  Google Scholar 

Feng D, Zhu W, You J, Shi X, Han P, Wei W, Wei Q, Yang L. Mitochondrial aldehyde dehydrogenase 2 represents a potential biomarker of biochemical recurrence in prostate cancer patients. Molecules. 2022;27(18):6000. https://doi.org/10.3390/molecules27186000.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Fan J, Chen T, Xu L, Liu P, Xiao L, Wu T, Zhou Q, Zheng Q, Liu C, Chan FL, Wu D. A novel ferroptosis-related gene prognostic index for prognosis and response to immunotherapy in patients with prostate cancer. Front Endocrinol. 2022;13:975623. https://doi.org/10.3389/fendo.2022.975623.

Article  Google Scholar 

Huang B, Song B, Xu C. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities. Nat Metab. 2020;2:132–41. https://doi.org/10.1038/s42255-020-0174-0.

Article  PubMed  Google Scholar 

Boele S, Siltari A, Raittinen P, Schleutker J, Taari K, Talala K, Tammela T, Auvinen A, Murtola T. Abstract 6486: Single nucleotide polymorphisms that predict serum cholesterol as a prostate cancer prognostic factor—a Mendelian randomization study. Can Res. 2023. https://doi.org/10.1158/1538-7445.am2023-6486.

Article  Google Scholar 

Škara L, Huđek Turković A, Pezelj I, Vrtarić A, Sinčić N, Krušlin B, Ulamec M. Prostate cancer-focus on cholesterol. Cancers. 2021;13(18):4696. https://doi.org/10.3390/cancers13184696.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Siltari A, Syvälä H, Lou YR, Gao Y, Murtola TJ. Role of lipids and lipid metabolism in prostate cancer progression and the tumor’s immune environment. Cancers. 2022;14(17):4293. https://doi.org/10.3390/cancers14174293.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dłubek J, Rysz J, Jabłonowski Z, Gluba-Brzózka A, Franczyk B. The correlation between lipid metabolism disorders and prostate cancer. Curr Med Chem. 2021;28(10):2048–61. https://doi.org/10.2174/0929867327666200806103744.

Article  CAS  PubMed  Google Scholar 

Li Z, Votava JA, Zajac GJM, Nguyen JN, Leyva Jaimes FB, Ly SM, Brinkman JA, De Giorgi M, Kaul S, Green CL, St Clair SL, Belisle SL, Rios JM, Nelson DW, Sorci-Thomas MG, Lagor WR, Lamming DW, Eric Yen CL, Parks BW. Integrating mouse and human genetic data to move beyond GWAS and identify causal genes in cholesterol metabolism. Cell Metab. 2020;31(4):741-754.e5. https://doi.org/10.1016/j.cmet.2020.02.015.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang N, Yang Y, Huang Z, Chen H. Deregulation of cholesterol homeostasis by a nuclear hormone receptor crosstalk in advanced prostate cancer. Cancers. 2022. https://doi.org/10.3390/cancers14133110.

Article  PubMed  PubMed Central  Google Scholar 

Gordon JA, Noble JW, Midha A, Derakhshan F, Wang G, Adomat HH, Tomlinson Guns ES, Lin YY, Ren S, Collins CC, Nelson PS, Morrissey C, Wasan KM, Cox ME. Upregulation of scavenger receptor B1 is required for steroidogenic and nonsteroidogenic cholesterol metabolism in prostate cancer. Can Res. 2019;79(13):3320–31. https://doi.org/10.1158/0008-5472.CAN-18-2529.

Article  CAS  Google Scholar 

Cheng Y, Meng Y, Li S, Cao D, Ben S, Qin C, Hua L, Cheng G. Genetic variants in the cholesterol biosynthesis pathway genes and risk of prostate cancer. Gene. 2021;774:145432. https://doi.org/10.1016/j.gene.2021.145432.

Article  CAS  PubMed  Google Scholar 

Thurtle DR, Jenkins V, Pharoah PD, Gnanapragasam VJ. Understanding of prognosis in non-metastatic prostate cancer: a randomised comparative study of clinician estimates measured against the PREDICT prostate prognostic model. Br J Cancer. 2019;121(8):715–8. https://doi.org/10.1038/s41416-019-0569-4.

Article  PubMed  PubMed Central  Google Scholar 

Meo N, Lasorsa F, Rutigliano M, Milella M, Ferro M, Battaglia M, Ditonno P, Lucarelli G. The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery. Expert Rev Mol Diagn. 2023;23:297–313. https://doi.org/10.1080/14737159.2023.2195553.

Article  CAS  PubMed  Google Scholar 

Huber F, Montani M, Sulser T, Jaggi R, Wild P, Moch H, Gevensleben H, Schmid M, Wyder S, Kristiansen G. Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer -what has gone wrong? A blueprint for the way forward in biomarker studies. Br J Cancer. 2015;112(1):140–8. https://doi.org/10.1038/bjc.2014.588.

Article  CAS  PubMed  Google Scholar 

Harlan SR, Cooperberg MR, Elkin E, Lubeck DP, Meng M, Mehta SS, Carroll PR. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE. J Urol. 2003;170(5):1804–7. https://doi.org/10.1097/01.ju.0000091641.34674.11.

Article  PubMed  Google Scholar 

Wang H, Liu Z, Wang Y, Han D, Du Y, Zhang B, He Y, Liu J, Xiong W, Zhang X, Gao Y, Shang P. Comprehensive analysis of fatty acid metabolism-related gene signatures for predicting prognosis in patients with prostate cancer. PeerJ. 2023. https://doi.org/10.7717/peerj.14646.

Article  PubMed  PubMed Central  Google Scholar 

Guo T, Wang J, Yan S, Meng X, Zhang X, Xu S, Ren S, Huang Y. A combined signature of glycolysis and immune landscape predicts prognosis and therapeutic response in prostate cancer. Front Endocrinol. 2022. https://doi.org/10.3389/fendo.2022.1037099.

Article  Google Scholar 

Feng D, Shi X, Zhang F, Xiong Q, Wei Q, Yang L. Energy metabolism-related gene prognostic index predicts biochemical recurrence for patients with prostate cancer undergoing radical prostatectomy. Front Immunol. 2022. https://doi.org/10.3389/fimmu.2022.839362.

Article  PubMed  PubMed Central  Google Scholar 

Scheinberg T, Mak B, Butler L, Selth L, Horvath LG. Targeting lipid metabolism in metastatic prostate cancer. Ther Adv Med Oncol. 2023;15:17588359231152840. https://doi.org/10.1177/17588359231152839.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eckhardt C, Sbiera I, Krebs M, Sbiera S, Spahn M, Kneitz B, Joniau S, Fassnacht M, Kübler H, Weigand I, Kroiss M. High expression of Sterol-O-Acyl transferase 1 (SOAT1), an enzyme involved in cholesterol metabolism, is associated with earlier biochemical recurrence in high risk prostate cancer. Prostate Cancer Prostatic Dis. 2021;25:484–90. https://doi.org/10.1038/s41391-021-00431-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang L, Wei R, Chen R, Fan G, Zhou J, Qi Z, Wang K, Wei Q, Wei X, Xu X. Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma. Comput Struct Biotechnol J. 2022;20:4402–14. https://doi.org/10.1016/j.csbj.2022.07.030.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao N, Qu C, Yang Y, Li H, Li Y, Zhu H, Long Z. Identification of a cholesterol metabolism-related prognostic signature for multiple myeloma. Sci Rep. 2023;13(1):19395. https://doi.org/10.1038/s41598-023-46426-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Trigueros-Motos L, van Capelleveen JC, Torta F, Castaño D, Zhang LH, Chai EC, Kang M, Dimova LG, Schimmel AWM, Tietjen I, Radomski C, Tan LJ, Thiam CH, Narayanaswamy P, Wu DH, Dorninger F, Yakala GK, Barhdadi A, Angeli V, Dubé MP, Singaraja RR. ABCA8 regulates cholesterol efflux and high-density lipoprotein cholesterol levels. Arterioscler Thromb Vasc Biol. 2017;37(11):2147–55. https://doi.org/10.1161/ATVBAHA.117.309574.